Search results for "PROGNOSIS"

showing 10 items of 2052 documents

Apparent Declining Prognostic Value of a Negative Stress Echocardiography Based on Regional Wall Motion Abnormalities in Patients With Normal Resting…

2019

Background: Cardiology guidelines identify the low-risk response during stress echocardiography as the absence of regional wall motion abnormalities. Methods: From 1983 to 2016, we enrolled 5817 patients (age 63±12 years; 2830 males) with suspected coronary artery disease, normal regional, and global left ventricular function at rest and during stress (exercise in 692, dipyridamole in 4291, and dobutamine in 834). Based on timing of enrollment, 4 groups were identified in chronological order of recruitment: years 1983 to 1989, group 1 (n=211); years 1990 to 1999, group 2 (n=1491); years 2000 to 2009, group 3 (n=3285); and years 2010 to 2016, group 4 (n=830). Results: There were 240 (4%) ev…

Malemedicine.medical_specialtyPopulationCoronary Artery Disease030204 cardiovascular system & hematologyVentricular Function LeftCohort StudiesCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusmedicineStress EchocardiographyHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineeducationReferral and Consultationeducation.field_of_studybusiness.industryHazard ratioReproducibility of ResultsMiddle AgedPrognosismedicine.diseaseDipyridamoleItalyConcomitantCardiologyFemaleDobutamineCardiology and Cardiovascular MedicinebusinessEchocardiography StressFollow-Up Studiesmedicine.drugCirculation: Cardiovascular Imaging
researchProduct

iScore for predicting institutional care after ischemic stroke: a population-based study.

2015

Background We assessed whether the iScore could predict the need for poststroke institutional care. Methods Patients with acute ischemic stroke living in Dijon, France, were recorded between 2006 and 2011, using a population-based stroke registry. The iScore was calculated for each patient. A logistic regression model was used to assess the performance of the iScore for predicting the need for placement in a care institution. The discrimination and calibration of the model were assessed using the c statistic and the Hosmer–Lemeshow goodness-of-fit test, respectively. Results Of the 1199 patients recorded, 124 were excluded because of early death and 95 because of missing for variables inclu…

Malemedicine.medical_specialtyPopulationLogistic regressionRehabilitation CentersRisk AssessmentPatient Care PlanningBrain IschemiaDecision Support TechniquesInterquartile rangePredictive Value of TestsRisk FactorsEpidemiologyMedicineHumansRegistrieseducationStrokeStatisticAgedAged 80 and overeducation.field_of_studyFramingham Risk Scorebusiness.industryRehabilitationMiddle Agedmedicine.diseasePrognosisConfidence intervalPatient DischargeNursing HomesStrokeLogistic ModelsEmergency medicinePhysical therapySurgeryFemaleNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction

2014

article Background: Silent atrial fibrillation (AF) has been suggested to be frequent after acute myocardial infarction (MI). Continuous ECG monitoring (CEM) has been shown to improve AF screening in patients at risk of stroke. Objectives: We aimed to assess the incidence and prognosis of silent AF in patients with acute MI. Methods:All the consecutive patients with acute MI were prospectively analyzed by CEM ≥ 48 h after admission. Silent AF was defined as asymptomatic episodes lasting at least 30 s. The population was divided into three groups: no-AF, silent AF and symptomatic AF. Results:Among the 849 patients, 135(16%) developedsilentAF and45(5%)symptomatic AF.Comparedwith the no-AF gro…

Malemedicine.medical_specialtyPopulationMyocardial InfarctionAsymptomatic[SHS]Humanities and Social SciencesInternal medicineAtrial FibrillationmedicineHumansProspective StudiesMyocardial infarctioneducationProspective cohort studyStrokeComputingMilieux_MISCELLANEOUSAgedAged 80 and overeducation.field_of_studyEjection fractionbusiness.industryIncidenceAge FactorsStroke VolumeAtrial fibrillationMiddle AgedPrognosismedicine.diseaseHeart failureCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Post Surgical Pyoderma Gangrenosum in flap surgery: diagnostic clues and treatment recommendations

2016

Background: Post Surgical Pyoderma Gangrenosum (PSPG) is a neutrophilic dermatosis causing aseptic necrotic ulcerations within surgical sites. It is often misdiagnosed as infection or ischemia and worsened by the inappropriate treatment. Therefore diagnostic clues must be identified and awareness for PSPG raised.Methods: We present two cases of PSPG after flap surgery and a review of the literature.Results: Seventeen cases of PSPG after flap surgery were found. Fever, pain and redness are the most common initial symptoms. In 63%, lesions were on the flap and the adjacent skin. In 63%, the donor site is also involved. Time to diagnosis was nine days to four years. Frequent debridement (89%) …

Malemedicine.medical_specialtyPost surgicalNecrosisTuberculosisPrognosiSettore MED/19 - Chirurgia PlasticaIschemia030230 surgeryAdrenal Cortex HormoneRisk AssessmentSeverity of Illness IndexSurgical Flaps030207 dermatology & venereal diseases03 medical and health sciencesPostoperative Complications0302 clinical medicineAdrenal Cortex HormonesPost Surgical Pyoderma GangrenosummedicineHumansflap surgeryskin and connective tissue diseasesAgedWound Healingbusiness.industryGeneral MedicineMiddle AgedPrognosismedicine.diseaseDermatologyPyoderma GangrenosumSurgerySurgical FlapDebridementFemaleSurgeryPostoperative ComplicationAseptic processingmedicine.symptombusinessBreast reconstructionComplicationPyoderma gangrenosumHumanActa Chirurgica Belgica
researchProduct

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation

2008

Aims: To gain insight in the prognosis and treatment of atrial fibrillation (AF) patients during 1-year follow-up in the Euro Heart Survey (EHS) on AF. Methods and results: The EHS enrolled 5333 AF patients in 2003-2004. One-year follow-up data were available for 80%. Of first detected AF patients, 46% did not have a recurrence during 1 year, paroxysmal AF largely remained paroxysmal AF (80%), and 30% of persistent AF progressed to permanent AF. Many treatment changes occurred since baseline. Oral anticoagulation was started in 19% and discontinued in 16% of all patients. Of patients initially on rhythm control 27% did not receive rhythm control during follow-up, whereas 15% of patients ini…

Malemedicine.medical_specialtyRate controlHeart DiseasesHeart diseasePrognosiHemorrhageRisk AssessmentAnticoagulationElectrocardiographyInternal medicineAtrial FibrillationHumansMedicineSinus rhythmProspective StudiesMortalityProspective cohort studyStrokeSurvival rateAgedProgressionmedicine.diagnostic_testbusiness.industryAnticoagulantAnticoagulantsAtrial fibrillationPrognosismedicine.diseaseManagementStrokeSurvival RateProspective StudieHeart DiseaseTreatment OutcomeHeart failureDisease ProgressionCardiologyRhythm controlFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyHumanEuropean Heart Journal
researchProduct

The predictive value of heart-type fatty acid-binding protein is independent from symptom duration in normotensive patients with pulmonary embolism.

2013

Heart-type fatty acid-binding protein (H-FABP) is a useful biomarker for risk stratification of patients with pulmonary embolism (PE). In patients with acute myocardial infarction, H-FABP plasma concentrations rise after 30 minutes and return to normal within 20-24 hours. We tested whether the predictive value of H-FABP is affected by the duration of symptoms prior to diagnosis in patients with PE.We prospectively studied 257 consecutive normotensive patients with confirmed symptomatic PE.Patients with acute (24 hours; n=150) symptom onset presented more often with syncope (28.7% vs. 6.5%; p0.001) compared to patients with symptoms ≥ 24 hours (n=107); other baseline characteristics, comorbi…

Malemedicine.medical_specialtyRenal function030204 cardiovascular system & hematologyFatty Acid-Binding Proteins03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineMyocardial infarctionProspective StudiesAgedbusiness.industryArea under the curveHematologyOdds ratioMiddle Agedmedicine.diseasePrognosisConfidence interval3. Good healthPulmonary embolismHeart-type fatty acid binding proteinCardiologyBiomarker (medicine)lipids (amino acids peptides and proteins)FemalebusinessPulmonary EmbolismFatty Acid Binding Protein 3Thrombosis research
researchProduct

Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function

2015

Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a renal tubular marker for early renal dysfunction [1]. Recent studies highlighted its role in predicting acute kidney injury (AKI) and clinical outcomes in a wide range of cardiovascular diseases [2], [3], [4] and [5]. However, in heart failure (HF), conflicting results have been reported [4], [5], [6] and [7] and some ambiguities still prevail about the prognostic utility of NGAL beyond standard prognosticators and traditional renal biomarkers. We aimed to evaluate the independent ability of serum NGAL for predicting long-term mortality in patients admitted for acute HF (AHF). We prospectively enrolled 206 patients consecuti…

Malemedicine.medical_specialtyRenal function030204 cardiovascular system & hematologyKidneyKidney Function TestsGastroenterology03 medical and health sciencesNormal renal function0302 clinical medicineText miningLipocalin-2Risk FactorsInternal medicinemedicineHumansIn patient030212 general & internal medicineProspective StudiesMortalityProspective cohort studyAgedAged 80 and overHeart Failurebusiness.industryPlasma neutrophilAcute heart failureMiddle Agedmedicine.diseasePrognosisNeutrophil gelatinase-associated lipocalinHeart failureRenal physiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersRenal function
researchProduct

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the Ather…

2009

Aims Chronic kidney disease is associated with increased risk of cardiovascular disease. Cystatin C is a promising marker to reliably mirror renal function. The role of cystatin C in patients with coronary artery disease (CAD) and normal or mildly reduced kidney function is the subject of current investigation. Methods and results In 2162 patients, over the whole spectrum of CAD, baseline cystatin C concentrations were measured. Patients with an estimated glomerular filtration rate of ≤60 mL/min per 1.73 m2 ( n = 295) were excluded. In patients with complete follow-up information ( n = 1827), 66 cardiovascular deaths were registered during a median follow-up of 3.65 years. Logarithmically t…

Malemedicine.medical_specialtyRenal functionCoronary Artery DiseaseCoronary artery diseasechemistry.chemical_compoundGermanyInternal medicinemedicineHumansProspective StudiesCystatin CRenal Insufficiency ChronicRisk factorAgedCreatininebiologybusiness.industryHazard ratioMiddle AgedPrognosismedicine.diseaseCystatin CchemistryCardiovascular Diseasesbiology.proteinCardiologyFemaleCystatinCardiology and Cardiovascular MedicinebusinessBiomarkersKidney diseaseEuropean Heart Journal
researchProduct

B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.

2008

In early stages of septic shock, impaired myocardial function plays an important prognostic role. In this context, B-type natriuretic peptide (BNP) has been shown to be a neurohumoral marker for left ventricular dysfunction, because myocardial strain and ischemia both increase BNP concentration. The present study was designed to test if BNP allows for identification of patients at risk for developing sepsis-induced myocardial depression and if an increased concentration of BNP is associated with an adverse outcome in patients with septic shock.In a prospective study, 93 patients with septic shock were divided into one group with normal ventricular function (left ventricular ejection fractio…

Malemedicine.medical_specialtyResuscitationCritical Caremedicine.drug_classIschemiaContext (language use)Critical Care and Intensive Care MedicineSepsisVentricular Dysfunction LeftInternal medicineIntensive careSepsisNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseasesProspective StudiesIntensive care medicineAgedSeptic shockbusiness.industryModels CardiovascularMiddle Agedmedicine.diseasePrognosisShock SepticROC CurveShock (circulatory)Multivariate Analysiscardiovascular systemCardiologyFemalemedicine.symptombusinesshuman activitieshormones hormone substitutes and hormone antagonistsBiomarkersCritical care medicine
researchProduct

Benefits of Statin Therapy Based on Plasma Carbohydrate Antigen 125 Values Following an Admission for Acute Heart Failure

2011

The prognostic benefit of statins in patients with heart failure is a topic of controversy. Under the hypothesis that statins may provide greater benefit in a subgroup of patients with heightened inflammatory activity, we sought to explore whether statins are associated with a decreased risk of long-term mortality in patients with acute heart failure based on elevated levels of carbohydrate antigen 125, a biomarker related to systemic congestion and proinflammatory status.We analysed 1222 consecutive patients admitted with acute heart failure in a single teaching center during a median follow-up of 20 months. carbohydrate antigen 125 was measured during index hospitalization and dichotomize…

Malemedicine.medical_specialtyRisk AssessmentProinflammatory cytokineCohort StudiesElectrocardiographyCause of DeathInternal medicinemedicineHumansProspective StudiesIntensive care medicineProspective cohort studyAgedCause of deathAged 80 and overHeart Failuremedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle AgedPrognosismedicine.diseaseCardiovascular DiseasesCA-125 AntigenHeart failureAcute DiseaseBiomarker (medicine)FemaleHydroxymethylglutaryl-CoA Reductase InhibitorsRisk assessmentbusinessElectrocardiographyBiomarkersFollow-Up StudiesCohort studyRevista Española de Cardiología (English Edition)
researchProduct